Hypercholesterolemia — Trials, FDA Actions & Pivotal Research
5 updates aggregated from openFDA and ClinicalTrials.gov, covering trial milestones, FDA actions, and pivotal publications about Hypercholesterolemia.
Synced daily from openFDA and ClinicalTrials.gov. Last sync: .
Drugs with Hypercholesterolemia trials
Recruiting trials by city
Cities where Hypercholesterolemia trials in our archive had recruiting sites. Each link lists every currently recruiting paid clinical trial at that location.
Updates
2026
- Results postedInclisiran Significantly Reduces LDL-C in Hypercholesterolemia, Lowers Muscle…· Apr 14, 2026· drug: Inclisiran
2025
- Results postedObicetrapib/Ezetimibe Combo Reduces LDL-C by 45.58% in Dyslipidemia Trial· Oct 8, 2025· drug: Obicetrapib
- Results postedObicetrapib Phase 3 Trial Reduces LDL-C by 29.94% in Dyslipidemia· Sep 19, 2025· drug: Obicetrapib
- Results postedInclisiran Monotherapy Reduces LDL-C by 46.5% in Primary Hypercholesterolemia· Aug 13, 2025· drug: Inclisiran
- Results postedObicetrapib Phase 3 Trial Reduces LDL-C in Heterozygous Familial…· Jun 11, 2025· drug: Obicetrapib